Article
NLRP3 inflammasome as a key molecular target underlying cognitive resilience in amyotrophic lateral sclerosis
9 Dec 2021
Abstract excerpt
Up to 50% of amyotrophic lateral sclerosis patients present with cognitive deficits in addition to motor dysfunction, but the molecular mechanisms underlying diverse clinical and pathological presentations remain poorly understood. There is therefore an unmet need to identify molecular drivers of cognitive dysfunction to enable better therapeutic targeting and prognostication. To address this, we employed a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
